Address

Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" Via dei Taurini, 19 00185 Roma - Italy
Stanza: 406

Contact Information

Call: 406

Email: giulia.fiscon@iasi.cnr.it

Personal site: www.iasi.cnr.it

Giulia Fiscon

Role: Research Associate

Research group: BIOSYS

Biomedical Engineer, PhD in Engineering in Computer Science, currently Researcher at Sapienza University. Her research activity is in bioinformatics and computational biology, focused on computational methods for studying complex biological systems to identify new biomarkers and therapeutic targets
Settori ERC: 
PE6_13 Bioinformatics, bio-inspired computing, and natural computing
LS2_11 Bioinformatics and computational biology

Recent publications

  1. 2022
    The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation
    S Amadio, Federica Conte, G Esposito, Giulia Fiscon, Paola Paci, Cinzia Volonté
  2. 2022
    SWIMmeR: an R-based software to unveiling crucial nodes in complex biological networks
    Paola Paci, Giulia Fiscon
  3. 2022
    SPINNAKER: an R-based tool to highlight key RNA interactions in complex biological networks
    Paola Paci, Giulia Fiscon
  4. 2022
    Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
    Tumino N., Besi F., Martini S., Di Pace A.L., Munari E., Quatrini L., Pelosi A., Fiore P.F., Giulia Fiscon, Paola Paci, Scordamaglia F., Covesnon M.G., Bogina G., Mingari M.C., Moretta L., Vacca P.
  5. 2022
    Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
    Giulia Fiscon, Pasquale Sibilio, Alessio Funari, Federica Conte, Paola Paci
  6. 2022
    Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects
    Paola Paci, Giulia Fiscon, Federica Conte, Rui Sheng Wang, Diane E. Handy, Lorenzo Farina, Joseph Loscalzo
  7. 2022
    Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation
    Mario Occhipinti, Roberto Ferrara, Martina Imbimbo, Vittorio Simeon, Giulia Fiscon, Corynne Marchal, Nicole Skoetz, Giuseppe Viscardi
  8. 2022
    A Transcriptome- and Interactome-Based Analysis Identifies Repurposable Drugs for Human Breast Cancer Subtypes
    Federica Conte, Pasquale Sibilio, Giulia Fiscon, Paola Paci
  9. 2022
    A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases
    Giulia Fiscon, Federica Conte, Lorenzo Farina, Paola Paci
  10. 2022
    Repurposing Histaminergic Drugs in Multiple Sclerosis
    S Amadio, Federica Conte, G Esposito, Giulia Fiscon, Paola Paci, Cinzia Volonté